Received Feb 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008873 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; Customer called to report TE. Vaccines were administered to patients.; This spontaneous report was received from a health care professional referring to a patient, age and gender not reported. Information regarding the patient's pertinent medical history, drug allergies/reactions, or concomitant medications was not provided. On 03-FEB-2026, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location not reported, lot number Z008873 which was verified to be valid, expiration not reported, but upon internal review established on 14-MAY-2027), the suspect vaccine was reconstituted with sterile diluent (Hollister-Stier) (lot number and expiration date not reported). The administered dose of the vaccine experienced a temperature excursion of -14°C up to -10°C (-13.6 C) for 2 hours, 5 minutes, it was not reported if the information was recorded by a data logger or not. There was no adverse effect reported.